A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease
This study has been completed.
First Posted: May 31, 2012
Last Update Posted: November 2, 2016
Information provided by (Responsible Party):